• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MEXICO S. DE R.L. DE CV HARMONY TRANSCATHETER PULMONARY VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELI

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MEXICO S. DE R.L. DE CV HARMONY TRANSCATHETER PULMONARY VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELI Back to Search Results
Model Number HARMONY-25
Medical Device Problem Codes Incomplete Coaptation (2507); Intravalvular regurgitation (4068)
Health Effect - Clinical Codes Pulmonary Valve Insufficiency/ Regurgitation (4452); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/19/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
It was reported that approximately 4 years and 5 months following the implant of a transcatheter pulmonic valve, the valve failed due to poor coaptation of the leaflets.Subsequently, a second valve was implanted valve-in-valve.
 
Additional Manufacturer Narrative
Updated data: b5.H6.Corrected data: b2.Outcome attributed to adverse event was erroneously omitted from the initial medwatch.Additional codes.Annex f code was erroneously omitted from the initial medwatch.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
It was reported that approximately 4 years and 5 months following the implant of a transcatheter pulmonic valve, the valve failed due to poor coaptation of the leaflets.Subsequently, a second valve was implanted valve-in-valve.Additional information was received that the patient experienced pulmonary regurgitation of unspecified severity as a result of the poor coaptation.There were no additional factors that contributed to the leaflet coaptation.
 
Event or Problem Description
Additional information was received that the severity of pulmonary regurgitation was moderate.Following the valve-in-valve, the reg urgitation resolved.
 
Additional Manufacturer Narrative
Image review: after (b)(4) the transcatheter pulmonary valve (tpv) failed due to poor coaptation of leaflets.Subsequently a second valve was implanted inside the first.An rv-pa gradient of 25-27 mmhg was measured by invasive catheterization.Pa injections showed regurgitation (estimated as moderate).It appears that a melody valve was implanted with a co-mounted non-medtronic stent, probably on a 24 mm balloon in balloon catheter, through a non-medtronic sheath.Updated data: b5.H6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HARMONY TRANSCATHETER PULMONARY VALVE
Common Device Name
PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELI
Manufacturer (Section D)
MEDTRONIC MEXICO S. DE R.L. DE CV
av. paseo del cucapah #10510
tijuana,bc 22210
MX  22210
Manufacturer (Section G)
MEDTRONIC MEXICO S. DE R.L. DE CV
av. paseo del cucapah #10510
tijuana,bc 22210
MX   22210
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key24431473
Report Number9617601-2026-01405
Device Sequence Number16028208
Product Code NPV
UDI-Device Identifier00763000338992
UDI-Public(01)00763000338992(17)220326
Combination Product (Y/N)N
Initial Reporter StateSC
Initial Reporter CountryUS
PMA/510(K) Number
P200046
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 04/14/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/26/2022
Device Model NumberHARMONY-25
Device Catalogue NumberHARMONY-25
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/19/2026
Supplement Date Received by Manufacturer02/24/2026
03/19/2026
Initial Report FDA Received Date02/24/2026
Supplement Report FDA Received Date03/16/2026
04/14/2026
Date Device Manufactured03/26/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age22 YR
Patient SexMale
Patient Weight26 KG
-
-